Tag Archives: March of Dimes

Making sense of the mess over Makena. Who wins and who loses?

It started in February. KV Pharmaceuticals submitted an application to the FDA to make Makena (17 hydroxyprogesterone or 17OP) an orphan drug. The application was endorsed by the March of Dimes. The actual quote from the medical director of the … Continue reading

Posted in Uncategorized | Tagged , , , | 2 Comments

Rep. Henry Waxman demands answers from Ther-Rx about Makena

Rep. Henry Waxman, Rep. Frank Pallone, Jr., and Rep. Diana DeGette sent a letter on March 24th to Gregory Divis, the CEO of Ther-Rx, regarding the pricing of Makena (see below). Of note, the honorable Mr. Waxman, Mr. Pallone, Jr, and Ms. … Continue reading

Posted in Uncategorized | Tagged , , , | 6 Comments

The March of Dimes really responds to Ther-Rx and price of Makena, well, sort of…

Today (March 23rd) Dr. Jennifer Howse of the March of Dimes (MOD) finally responded to the egregious price gouging/extortion that is Makena (17 Alpha-hydroxyprogesterone caproate, or 17OP, newly packaged as an orphan drug). As we all know, this travesty was … Continue reading

Posted in Uncategorized | Tagged , , , , | 9 Comments

The longer the March of Dimes takes to act on Makena, the worse it gets

This whole Makena thing just keeps getting worse. Worse for women, because co-payments have sky rocketed and worse for the March of Dimes, whose every move proves they are just digging themselves a deeper hole. I read yesterday (March 22) … Continue reading

Posted in Uncategorized | Tagged , , , | 2 Comments

Questions for the March of Dimes about Makena

The senior vice president (SVP) of marketing for the March of Dimes (MOD) reached out to me via e-mail on Monday about Makena pricing. He wanted to let me know the March of Dimes is “doing all we can to ensure access for … Continue reading

Posted in Uncategorized | Tagged , , , | 8 Comments

The impact of Makena on Medicaid: KV Pharamceuticals’ extortion of tax payers

Makena, KV Pharmaceuticals version of 17 alpha-hydroxyprogesterone caproate or 17OP (for prevention of preterm labor) is priced at $1500 a shot (up from $10 a shot prior to the meddling of the FDA). Considering most women who are eligible will … Continue reading

Posted in Uncategorized | Tagged , , , , , | 7 Comments

March of Dimes response to Makena pricing reveals they are woefully out of touch

Preemie message boards are all fired up by KV Pharmaceutical’s pricing of 17 Alpha-hydroxy progesterone caproate (17P, a hormone than can help prevent premature delivery for some women who have previously delivered prematurely). Once KV was awarded the patent, the … Continue reading

Posted in Uncategorized | Tagged , , , | 19 Comments